Deanna Kelly, PharmD, BCPP
Professor of Psychiatry
Director, Treatment Research Program
Maryland Psychiatric Research Center
University of Maryland
Baltimore, MD

Deanna L. Kelly, PharmD, BCPP, is Professor of Psychiatry at University of Maryland Baltimore School of Medicine and Affiliate Professor in the School of Pharmacy. She is currently Director and Chief of the Treatment Research Program at the Maryland Psychiatric Research Center (MPRC). Dr. Kelly received her Bachelor of Science and Doctorate in Pharmacy at Duquesne University in Pittsburgh, PA. She completed residency training in psychiatric pharmacy practice at the University of Maryland in 1997 and became board certified in psychiatric pharmacy practice in 1998. 

Dr. Kelly has led and been involved in numerous clinical trials in schizophrenia and has been active in psychopharmacology research for the past 22 years. She has been continuously funded by NIMH, NIDA, and private foundations such as the Stanley Medical Research Institute and the Maryland Innovation Initiative for over 20 years. 

Dr. Kelly has coauthored and authored 20 books and book chapters, published 210 peer-reviewed articles, presented over 160 posters and has given over 150 invited lectures. She has coauthored three editions of the book entitled “Pharmacologic Treatment of Schizophrenia.” She also authors the Schizophrenia chapter for “Pharmacotherapy, Principles and Practice.” Among many other activities she is a content expert for the CSS SMI Advisor group, Vice Chair of the State of Maryland Department of Mental Health Institutional Review Board and Chairs the Department of Psychiatry Faculty Mentoring Committee. 

She is the recipient of the 2017 Maltz Prize for Innovative and Promising Schizophrenia Research from the Brain and Behavior Research Foundation and recently award an R37 MERIT grant  award from NIMH for exceptional work in schizophrenia research.